nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aggregation of data from 4 clinical studies demonstrating efficacy of single-dose doxycycline postexposure for prevention of the spirochetal infections: Lyme disease, syphilis, and tick-borne relapsing fever
|
Wormser, Gary P. |
|
|
99 |
4 |
p. |
artikel |
2 |
Burden and risk factors for inappropriate Clostridioides Difficile infection testing among hospitalized patients
|
Axenfeld, Ellen |
|
|
99 |
4 |
p. |
artikel |
3 |
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models
|
Cristinacce, Andrew |
|
|
99 |
4 |
p. |
artikel |
4 |
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
|
Serei, Virian D. |
|
|
99 |
4 |
p. |
artikel |
5 |
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities
|
Orner, Erika P |
|
|
99 |
4 |
p. |
artikel |
6 |
Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients
|
Wu, Ziwei |
|
|
99 |
4 |
p. |
artikel |
7 |
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
|
Valcourt, Emelissa J. |
|
|
99 |
4 |
p. |
artikel |
8 |
Evaluation of BD Phoenix and Microscan WalkAway for determination of fosfomycin susceptibility in Staphylococcus aureus
|
Bondi, Alessandro |
|
|
99 |
4 |
p. |
artikel |
9 |
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)
|
Cotton, Seb |
|
|
99 |
4 |
p. |
artikel |
10 |
Excellent performance of CHROMagarTM LIN-R to selectively screen for linezolid-resistant enterococci and staphylococci
|
Layer, Franziska |
|
|
99 |
4 |
p. |
artikel |
11 |
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report
|
Witting, Celeste |
|
|
99 |
4 |
p. |
artikel |
12 |
Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2
|
Furuya, Andrea K.M. |
|
|
99 |
4 |
p. |
artikel |
13 |
Polymyxin NP tests (from colonies and directly from blood cultures): accurate and rapid methodologies to detect polymyxin B susceptibility among Enterobacterales
|
Collar, Gabriela da S. |
|
|
99 |
4 |
p. |
artikel |
14 |
Prostatic abscess: clinical features, management, and outcomes of a “Stealth” infection: retrospective case series and review of the literature
|
Wooster, Margaux E. |
|
|
99 |
4 |
p. |
artikel |
15 |
Rapid and accurate eXDR screening: use Xpert Carba-R® with FecalSwab®
|
Farfour, Eric |
|
|
99 |
4 |
p. |
artikel |
16 |
Staphylococcus pettenkoferi-positive Blood cultures in Hospitalized Patients in a Multi-site Tertiary Center
|
Eke, Uzoamaka A |
|
|
99 |
4 |
p. |
artikel |
17 |
Surrogate testing of oral third-generation cephalosporin susceptibility to common uropathogens
|
Watson, Joshua R. |
|
|
99 |
4 |
p. |
artikel |
18 |
The activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study
|
Huang, David B |
|
|
99 |
4 |
p. |
artikel |
19 |
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response
|
Dittadi, Ruggero |
|
|
99 |
4 |
p. |
artikel |